The proven technology to invest wisely

USA Change Macroaxis User Registration

HomePortfoliosSolutionsTools

Portfolio MasterPortfolio ManagerRebalancingPortfolio AnalyzerOptimizerSuggestion

US Market Closed: May 27, 01:22 AM 2012

MYL WPI MRX PRX AKRX HITK

NYSE 7,534 18.032

Processing
Collecting data for SLXP

Salix story

Companies

Insiders

Advisers

More Actions
- Equity Search
- Advanced Search
- Market Screener
- Adviser Directory
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatility
- Import Equities

Salix Pharmaceuticals Ltd.

Stock@American Stock Exchange

Use Salix Pharmaceuticals Ltd. story together with your assets to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.

Spurs top Jazz for 11th straight win

At www.ksdk.com

Salt Lake City, UT (Sports Network) - Tony Parker had 23 points and 11 assists on Monday and the San Antonio Spurs extended their winning streak to 11 games with a 106-102 victory over the Utah Jazz. Tony Parker leads Spurs past slumping Jazz, 106-102 - Salt Lake Tribune San Antonio Spurs (22-9) at Utah Jazz (15-15), 9 pm (ET) - MiamiHerald.com

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Price

Timeline

Similar stores for Salix

Few days ago at www.itbusinessnet.com

View

Analyst Moves: SLXP, WYNN

IT Business Net - May 10, 2012 By GrabNetworks Salix Pharmaceuticals (SLXP) today had its estimates increased by Jefferies (JEF) after the company beat earnings estimates.

Few days ago at zolmax.com

View

Zacks Reiterates Neutral on Salix Pharmaceuticals (SLXP)

Junction Report - May 9, 2012 Salix Pharmaceuticals (NASDAQ: SLXP)'s stock had its ?neutral? rating restated by Zacks in a report issued on Wednesday. They currently have a $55.00 target price on the stock. Auriga Reiterates Hold on Salix Pharmaceuticals (SLXP) - Movie News Guide (blog)

Few days ago at www.streetinsider.com

View

Jefferies Boosts Price Target on Salix Pharmaceuticals (SLXP)

StreetInsider.com (subscription) - May 8, 2012 Jefferies analysts raised their price target on Salix Pharmaceuticals (NASDAQ: SLXP) from $54.00 to $63.00 while maintaining a BUY rating on the company.

Discuss Salix story

Follow Salix News with your standard RSS feed, custom widget, or your favorite social app

Get Widget

Syndicate

Salix News

Salix Research Report

Price to Earning Comparison

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investor monitor on a daily basis. Holding a low PE stock is less risky because. When a company's profitability fall, it is likely that earnings will also go down..In other words, if you start from a lower position your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

More...